Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 111 | Longs Won 60/111 54% | Profit Factor 1.59 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $7,616.39 |
| Average Win $3,771.25 | Best Trade (Oct 02) $56,536.76 | Sharpe Ratio -50.76 |
| Average Loss -$2,787.77 | Worst Trade (May 17) -$23,102.17 | Z-Score -0.31 (24.64%) |
| Commissions $0 | Avg. Trade Length 1m 3w 2d | Expectancy $796.89 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.03% | 0.22% | 0.94% | 2.92% | 7.4% | 16.24% | 32.07% | 58.45% |
| Consecutive Losing Trades | 68 | 61 | 54 | 48 | 41 | 34 | 27 | 20 | 14 | 7 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 235.65 | $173,156.92 | $188,454.64 | - | $15,297.72 | 8.83% | +2.745% |